Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators

$TFXPress releaseAug 4, 2026, 8:00 AM ETRead the release

Teleflex Medical OEM has launched as an independent company named INGENYX following its acquisition by Montagu and Kohlberg and carve-out from Teleflex Incorporated (TFX). The new entity focuses on custom-engineered interventional catheters, sutures, and other medical technologies, operating seven facilities across the US, Ireland, and Mexico.

Key figures

Montagu aum
€15 billion
Kohlberg aum
$17 billion
Facility count
7
Years experience
40

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    TFX: Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators — AI Analysis | Signal8